Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Leurs

Showing results (281-290 of 285) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 285 results.
Molecular Pharmacology|February 12, 2024
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3Aurelien M Zarca, Ilze Adlere, Cristina P Viciano, et al.
Drug Discovery Today|April 17, 2017
Kinetics for Drug Discovery: an industry-driven effort to target drug residence timeDoris A Schuetz, Wilhelmus Egbertus Arnout de Witte, Yin Cheong Wong, et al.
Journal of Medicinal Chemistry|April 20, 2018
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal ActivityAntoni R Blaazer, Abhimanyu K Singh, Erik de Heuvel, et al.
Science Advances|December 6, 2024
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmissionPaula-Josefina Gomez-Gonzalez, Antima Gupta, Laura G Drought, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 29

Showing results (281-290 of 285) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 285 results.
Molecular Pharmacology|February 12, 2024
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3Aurelien M Zarca, Ilze Adlere, Cristina P Viciano, et al.
Drug Discovery Today|April 17, 2017
Kinetics for Drug Discovery: an industry-driven effort to target drug residence timeDoris A Schuetz, Wilhelmus Egbertus Arnout de Witte, Yin Cheong Wong, et al.
Journal of Medicinal Chemistry|April 20, 2018
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal ActivityAntoni R Blaazer, Abhimanyu K Singh, Erik de Heuvel, et al.
Science Advances|December 6, 2024
Inhibitors of malaria parasite cyclic nucleotide phosphodiesterases block asexual blood-stage development and mosquito transmissionPaula-Josefina Gomez-Gonzalez, Antima Gupta, Laura G Drought, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 29